Verdence Capital Advisors’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-8,877
Closed -$200K 635
2024
Q3
$200K Buy
8,877
+418
+5% +$9.56K 0.02% 619
2024
Q2
$209K Buy
8,459
+117
+1% +$3.32K 0.02% 565
2024
Q1
$275K Buy
8,342
+501
+6% +$17.1K 0.03% 503
2023
Q4
$285K Buy
7,841
+21
+0.3% +$721 0.03% 478
2023
Q3
$287K Buy
7,820
+368
+5% +$14.7K 0.03% 448
2023
Q2
$286K Buy
7,452
+1,275
+21% +$47.1K 0.03% 428
2023
Q1
$253K Buy
+6,177
New +$258K 0.03% 473
2022
Q4
Sell
-7,261
Closed -$201K 497
2022
Q3
$201K Buy
7,261
+189
+3% +$6.13K 0.03% 489
2022
Q2
$210K Sell
7,072
-505
-7% -$17K 0.03% 474
2022
Q1
$309K Buy
7,577
+257
+4% +$11K 0.04% 423
2021
Q4
$350K Buy
+7,320
New +$328K 0.04% 365

Other funds holding ADNT

Verdence Capital Advisors's ADNT Position: Q4 2024 in Review

Verdence Capital Advisors sold out of Adient (ADNT) in Q4 2024, closing a stake of 8,877 shares — an estimated $200K sold.

Verdence Capital Advisors first reported a position in ADNT in Q4 2021 and held it in 11 quarters. The position peaked at $350K in Q4 2021. 270 funds tracked by Wall St. Rank hold ADNT as of Q4 2024.

  • Verdence Capital Advisors reported no remaining Adient position as of Q4 2024 after selling out during the quarter.
  • Verdence Capital Advisors sold 8,877 Adient shares in Q4 2024, an estimated $200K.
  • Verdence Capital Advisors first reported a position in Adient in Q4 2021 and held it in 11 quarters.
  • Verdence Capital Advisors's Adient position peaked at $350K in Q4 2021.
  • 270 funds tracked by Wall St. Rank held Adient as of Q4 2024.

Based on Verdence Capital Advisors's 13F filing for Q4 2024, filed 6 Feb 2025.